These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 16101176)

  • 1. Expression of deltaNp63 in squamous cell carcinoma of the esophagus.
    Morita M; Uramoto H; Nakata S; Ono K; Sugaya M; Yoshimatsu T; Oyama T; Hanagiri T; Sugio K; Yasumoto K
    Anticancer Res; 2005; 25(5):3533-9. PubMed ID: 16101176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A lack of prognostic significance regarding DeltaNp63 immunoreactivity in lung cancer.
    Iwata T; Uramoto H; Sugio K; Fujino Y; Oyama T; Nakata S; Ono K; Morita M; Yasumoto K
    Lung Cancer; 2005 Oct; 50(1):67-73. PubMed ID: 15950316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ubiquitous p63 expression in human esophageal squamous cell carcinoma.
    Hara T; Kijima H; Yamamoto S; Kenmochi T; Kise Y; Tanaka H; Chino O; Shimada H; Takazawa K; Tanaka M; Inokuchi S; Makuuchi H
    Int J Mol Med; 2004 Aug; 14(2):169-73. PubMed ID: 15254760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of the p53 family in lung cancer.
    Uramoto H; Sugio K; Oyama T; Nakata S; Ono K; Nozoe T; Yasumoto K
    Anticancer Res; 2006; 26(3A):1785-90. PubMed ID: 16827107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of p53-related protein p63 in the gastrointestinal tract and in esophageal metaplastic and neoplastic disorders.
    Glickman JN; Yang A; Shahsafaei A; McKeon F; Odze RD
    Hum Pathol; 2001 Nov; 32(11):1157-65. PubMed ID: 11727253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of p63 (TA and deltaN isoforms) in human primary well differentiated buccal carcinomas.
    Chen YK; Hsue SS; Lin LM
    Int J Oral Maxillofac Surg; 2004 Jul; 33(5):493-7. PubMed ID: 15183414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced expression of p63 has prognostic implications for patients with esophageal squamous cell carcinoma.
    Takahashi Y; Noguchi T; Takeno S; Kimura Y; Okubo M; Kawahara K
    Oncol Rep; 2006 Feb; 15(2):323-8. PubMed ID: 16391849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential expression of p63 isoforms in normal tissues and neoplastic cells.
    Nylander K; Vojtesek B; Nenutil R; Lindgren B; Roos G; Zhanxiang W; Sjöström B; Dahlqvist A; Coates PJ
    J Pathol; 2002 Dec; 198(4):417-27. PubMed ID: 12434410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expression of DeltaNp63 protein in nasopharyngeal carcinoma and its significance].
    Liao ZL; Deng ZL; Zhang B; Xie KS
    Ai Zheng; 2004 Mar; 23(3):288-91. PubMed ID: 15025959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p63 overexpression associates with poor prognosis in head and neck squamous cell carcinoma.
    Lo Muzio L; Santarelli A; Caltabiano R; Rubini C; Pieramici T; Trevisiol L; Carinci F; Leonardi R; De Lillo A; Lanzafame S; Bufo P; Piattelli A
    Hum Pathol; 2005 Feb; 36(2):187-94. PubMed ID: 15754296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of p63 and deltaNp63 (p40) protein expression and gene amplification in esophageal carcinogenesis.
    Geddert H; Kiel S; Heep HJ; Gabbert HE; Sarbia M
    Hum Pathol; 2003 Sep; 34(9):850-6. PubMed ID: 14562279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired p63 expression associates with poor prognosis and uroplakin III expression in invasive urothelial carcinoma of the bladder.
    Koga F; Kawakami S; Fujii Y; Saito K; Ohtsuka Y; Iwai A; Ando N; Takizawa T; Kageyama Y; Kihara K
    Clin Cancer Res; 2003 Nov; 9(15):5501-7. PubMed ID: 14654529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DeltaNp63 isoforms differentially regulate gene expression in squamous cell carcinoma: identification of Cox-2 as a novel p63 target.
    Boldrup L; Coates PJ; Gu X; Nylander K
    J Pathol; 2009 Aug; 218(4):428-36. PubMed ID: 19391123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deregulated p21(WAF1) overexpression impacts survival of surgically resected esophageal squamous cell carcinoma patients.
    Goan YG; Hsu HK; Chang HC; Chou YP; Chiang KH; Cheng JT
    Ann Thorac Surg; 2005 Sep; 80(3):1007-16. PubMed ID: 16122475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of VEGF-C correlates with a poor prognosis based on analysis of prognostic factors in 73 patients with esophageal squamous cell carcinomas.
    Liu P; Chen W; Zhu H; Liu B; Song S; Shen W; Wang F; Tucker S; Zhong B; Wang D
    Jpn J Clin Oncol; 2009 Oct; 39(10):644-50. PubMed ID: 19648590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. E-cadherin loss and Delta Np73L expression in oral squamous cell carcinomas showing aggressive behavior.
    Foschini MP; Cocchi R; Morandi L; Marucci G; Pennesi MG; Righi A; Tosi AL; de Biase D; Pession A; Montebugnoli L
    Head Neck; 2008 Nov; 30(11):1475-82. PubMed ID: 18704970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced membranous beta-catenin protein expression is associated with metastasis and poor prognosis in squamous cell carcinoma of the esophagus.
    Hsu PK; Li AF; Wang YC; Hsieh CC; Huang MH; Hsu WH; Hsu HS
    J Thorac Cardiovasc Surg; 2008 May; 135(5):1029-35. PubMed ID: 18455580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of epidermal growth factor receptor in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome.
    Wang KL; Wu TT; Choi IS; Wang H; Resetkova E; Correa AM; Hofstetter WL; Swisher SG; Ajani JA; Rashid A; Albarracin CT
    Cancer; 2007 Feb; 109(4):658-67. PubMed ID: 17211865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p63 immunoreactivity in lung cancer: yet another player in the development of squamous cell carcinomas?
    Pelosi G; Pasini F; Olsen Stenholm C; Pastorino U; Maisonneuve P; Sonzogni A; Maffini F; Pruneri G; Fraggetta F; Cavallon A; Roz E; Iannucci A; Bresaola E; Viale G
    J Pathol; 2002 Sep; 198(1):100-9. PubMed ID: 12210069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of the expression of Smad6 and Smad7, as inhibitory Smads of the TGF-beta superfamily, in esophageal squamous cell carcinoma.
    Osawa H; Nakajima M; Kato H; Fukuchi M; Kuwano H
    Anticancer Res; 2004; 24(6):3703-9. PubMed ID: 15736400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.